These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 169139)
21. In vitro inhibition of cyclic 3' 5',-AMP-phosphodiesterase by a group of structural analogues of glaucine. Petkov V; Stancheva S Acta Physiol Pharmacol Bulg; 1980; 6(3):38-47. PubMed ID: 6269351 [TBL] [Abstract][Full Text] [Related]
22. Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro. Truss MC; Uckert S; Stief CG; Schulz-Knappe P; Hess R; Forssmann WG; Jonas U Urology; 1995 May; 45(5):893-901. PubMed ID: 7747383 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of adenosine 3',5'-monophosphate phosphodiesterase by nicotinamide and its homologues in vitro. Shimoyama M; Kawai M; Nasu S; Shioji K; Hoshi Y Physiol Chem Phys; 1975; 7(2):125-32. PubMed ID: 239431 [TBL] [Abstract][Full Text] [Related]
24. Relaxant effect of YM976, a novel phosphodiesterase 4 inhibitor, on bovine tracheal smooth muscle. Moriuchi H; Nakahara T; Maruko T; Sakamoto K; Ishii K Eur J Pharmacol; 2003 May; 470(1-2):57-64. PubMed ID: 12787831 [TBL] [Abstract][Full Text] [Related]
25. Morphone abstinence and quasi-abstinence effects after phosphodiesterase inhibitors and naloxone. Francis DL; Roy AC; Collier HO Life Sci; 1975 Jun; 16(12):1901-6. PubMed ID: 168452 [No Abstract] [Full Text] [Related]
26. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases. Miyamoto M; Takayanagi I; Ohkubo H; Takagi K Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797 [No Abstract] [Full Text] [Related]
27. Inhibition of a high molecular weight cyclic 3',5'-nucleotide phosphodiesterase isolated from rat liver. Rhoads AR; Olowofoyeku AK; West WL; Morris HP Biochem Pharmacol; 1976 Jan; 25(1):97-9. PubMed ID: 175802 [No Abstract] [Full Text] [Related]
28. Studies on the effect of nicotinamide and ethylnicotinic acid on cyclic AMP phosphodiesterase from rat liver. Hoshi Y Bull Osaka Med Sch; 1975 Oct; 21(2):77-91. PubMed ID: 181108 [No Abstract] [Full Text] [Related]
29. Effect of thyroid hormone on cyclic AMP phosphodiesterase in rat kidney. Hagino Y; Uematsu T; Tachibana M; Tsuru H Jpn J Pharmacol; 1980 Aug; 30(4):521-8. PubMed ID: 6162987 [TBL] [Abstract][Full Text] [Related]
30. Effect of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propranolol on adenylate cyclase and 3,5'-cyclic AMP phosphodiesterase in vitro. Yamashita Y; Kawai M; Hotta K Jpn J Pharmacol; 1976 Jun; 26(3):391-4. PubMed ID: 185445 [No Abstract] [Full Text] [Related]
31. The metabolism of cyclic nucleotides in the guinea-pig pancreas. Cyclic AMP phosphodiesterase and cyclic GMP phosphodiesterase. Methven P; Lemon M; Bhoola K Biochem J; 1980 Feb; 186(2):491-8. PubMed ID: 6246887 [TBL] [Abstract][Full Text] [Related]
32. Influence of tricyclic antidepressants on the adenylate cyclase-phosphodiesterase system in the rat cortex. Palmer GC Neuropharmacology; 1976 Jan; 15(1):1-7. PubMed ID: 176608 [No Abstract] [Full Text] [Related]
33. Effect of different xanthines and phosphodiesterase inhibitors on c-fos expression in rat striatum. Svenningsson P; Johansson B; Fredholm BB Acta Physiol Scand; 1995 May; 154(1):17-24. PubMed ID: 7572198 [TBL] [Abstract][Full Text] [Related]
34. Circadian periodicity a neurospora: alteration by inhibitors of cyclic AMP phosphodiesterase. Feldman JF Science; 1975 Nov; 190(4216):789-90. PubMed ID: 173018 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator. Sakamoto N; Terai M; Takenaka T; Maeno H Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059 [No Abstract] [Full Text] [Related]
37. Hypertrophied right hearts get two for the price of one: can inhibiting phosphodiesterase type 5 also inhibit phosphodiesterase type 3? Kass DA Circulation; 2007 Jul; 116(3):233-5. PubMed ID: 17638937 [No Abstract] [Full Text] [Related]
38. Fused pyrimidine based inhibitors of phosphodiesterase 7 (PDE7): synthesis and initial structure-activity relationships. Kempson J; Pitts WJ; Barbosa J; Guo J; Omotoso O; Watson A; Stebbins K; Starling GC; Dodd JH; Barrish JC; Felix R; Fischer K Bioorg Med Chem Lett; 2005 Apr; 15(7):1829-33. PubMed ID: 15780616 [TBL] [Abstract][Full Text] [Related]
39. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases. Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182 [No Abstract] [Full Text] [Related]
40. Hydrolysis of N-methyl-D-aspartate receptor-stimulated cAMP and cGMP by PDE4 and PDE2 phosphodiesterases in primary neuronal cultures of rat cerebral cortex and hippocampus. Suvarna NU; O'Donnell JM J Pharmacol Exp Ther; 2002 Jul; 302(1):249-56. PubMed ID: 12065724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]